DAE HWA PHARMACEUTICAL CO., LTD.

Highlights DAE HWA Pharmaceutical Co., Ltd.

Equities

A067080

KR7067080002

End-of-day quote Korea S.E. Other stock markets 03:30:00 30/05/2024 am IST			5-day change	1st Jan Change
9,670 ^KRW	-0.10%		-2.72%	+3.09%

2022	DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) dropped from S&P Global BMI Index	CI
2019	Mediforum Co.,Ltd. acquired 13.9% stake in C-TRI Co., Ltd. from DAE HWA Pharmaceutical Co., Ltd. and Wanjoo Kim for KRW 20.2 billion.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mediforum Co.,Ltd. acquired 13.9% stake in C-TRI Co., Ltd. from DAE HWA Pharmaceutical Co., Ltd. and Wanjoo Kim for KRW 20.2 billion.	05/19/05	CI
DAE HWA Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 6, 2019, has expired.	06/19/06	CI
DAE HWA Pharmaceutical Co., Ltd. announces an Equity Buyback for 360,000 shares.	06/19/06	CI
DAE HWA Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	06/19/06	CI
DAE HWA Pharmaceutical Co., Ltd. cancelled the acquisition of REDOXBIL CO.,LTD.	31/14/31	CI
DAE HWA Pharmaceutical Co., Ltd. agreed to acquire REDOXBIL CO.,LTD. for KRW 1.1 billion.	31/13/31	CI
Dae Hwa Pharmaceutical Co., Ltd Proposes Dividend	28/13/28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer